XNAS: FATE
Fate Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline ...
Read More
2.58
0.05
(1.98%)
1.0M
XNAS Volume
XNAS 22 Sep, 2026 2:05 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Fate Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..